While North America and Europe have long led the world in biotechnology, 2026 marks a definitive shift toward the East. Countries like China, India, and South Korea are investing billions into their genomic infrastructure. With massive populations and a growing middle class that is increasingly health-conscious, the demand for genetic testing in Asia is outpacing every other region on the...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt